CRIS Q2 2017 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+22.7% YoY

Gross Profit

$2M95.3% margin

Operating Income

-$13M-636.1% margin

Net Income

-$14M-683.6% margin

EPS (Diluted)

$-9.80

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$64M

Total Liabilities

$55M

Stockholders' Equity

$9M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+22.7%
Gross Profit	$2M	$2M	+24.0%
Operating Income	-$13M	-$11M	-22.7%
Net Income	-$14M	-$11M	-24.8%

Revenue Segments

Drug Development Royalty

$100,000100%